Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Pfeiffer Vacuum Technology AG intends to acquire Alcatel-Lucent?s Vacuum Technology unit ?Adixen?

November 4, 2010 9:38 am | by I-Micronews | News | Comments

Pfeiffer Vacuum Technology AG intends to acquire Alcatel-Lucent?s Vacuum Technology Unit which is headquartered in Annecy, France.

Hospira Symbiq One-Channel and Two-Channel Infusers: Class I Recall - Motor Encoder Failures

November 4, 2010 9:38 am | by U.S. Food & Drug Administration | News | Comments

Infusers may cease operation and exhibit an audible and visual alarm. Delay or interruption of infusion therapy may result in serious injury or death.

Class I Medical Device Recall: Hospira Symbiq One and Two Channel Infuser

November 4, 2010 9:37 am | by U.S. Food & Drug Administration | News | Comments

The Symbiq One and Two-Channel Infusers are infusion pumps intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural...

Advertisement

FDA Reclassifies Certain Digital Mammography Devices

November 4, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Nov. 4, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that it is easing the pathway to market for mammography systems that produce computerized X-ray images of the entire breast. (Logo:  ...

TOPICS:

AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System

November 4, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

COLD SPRING HARBOR, N.Y., Nov. 4, 2010 /- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program.  This Federal grant...

TOPICS:

Decline in Pharmaceutical Sales in The Cape Coral, Fla. Market Due to High Uninsurance Rates and Generic Utilization Will Be Offset by the Establishment of High-Risk Pool and ...

November 4, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Nov. 4, 2010 /- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while the Cape Coral, Fla. market will face a decline in pharmaceutical sales due to rising uninsurance and increased generic utilization, the development of...

TOPICS:

CardioGenics Raises $1.9 Million in Private Placement

November 4, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Nov. 4, 2010 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH ) announced today that it has completed a private placement under which it has raised $1,930,575. The shares issued in connection with the private placement do not have registration rights and are,...

TOPICS:

Information on Security Screening of People

November 4, 2010 9:30 am | by U.S. Food & Drug Administration | News | Comments

People screening is the practice of searching people before allowing access to a secure area, for example at airports, court houses, prisons, or museums. People screening electronic products are used to detect concealed weapons, explosives or other...

TOPICS:
Advertisement

NxStage posts narrower 3Q loss as sales increase

November 4, 2010 8:47 am | by The Associated Press | News | Comments

Dialysis products maker NxStage Medical Inc. posted a smaller third-quarter loss Thursday, reporting greater demand from the at-home and critical care markets.The company said it pared its loss to $8.2 million, or 17 cents per share, from $10 million, or 22 cents per share, one year ago....

Edwards Lifesciences to Present at the Credit Suisse Healthcare Conference(2)

November 4, 2010 8:46 am | News | Comments

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Credit Suisse Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona on Thursday, November 11, 2010.Thomas M. Abate,...

Abiomed fiscal 2Q loss narrows, Impella sales rise

November 4, 2010 7:45 am | by The Associated Press | News | Comments

Abiomed Inc. said Thursday its fiscal 2011 second-quarter loss narrowed as the heart device maker saw a jump in revenue from its Impella systems.The Danvers, Mass., company said it lost $3.2 million, or 9 cents per share, in the three months that ended Sept. 30. That compares with a loss of...

Business-to-Business Magazine Names Orion HealthCorp CEO as Top 25 Entrepreneur for 2010

November 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Nov. 4, 2010 /- Orion HealthCorp , Inc., a leader in medical billing and practice management for more than 20 years, announced today that its President and CEO, Terrence L. Bauer, has been named to Business-to-Business Magazine's 2010 Top 25 Entrepreneur list. Bauer ranked No. 12...

TOPICS:

SPO Announces Completion of Rebranding Program

November 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SPO Announces Completion of Rebranding Program -- NEW YORK, November 4, 2010 /-

TOPICS:

ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System

November 4, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Nov. 4, 2010 /PRNewswire-USNewswire/ -- ECRI Institute , an independent nonprofit that researches the best approaches to improving patient care, has been awarded a multi-year contract from the U.S. Agency for Healthcare Research and Quality (AHRQ) to establish the...

TOPICS:

Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results

November 4, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Nov. 4, 2010 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announces third quarter financial results for 2010. The merger of Biovail Corporation (Legacy Biovail) and Valeant Pharmaceuticals International (Legacy Valeant) was completed on...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading